Top

International Journal of Colorectal Disease

Published in:

01-03-2004 | Original Article

Total cystectomies in the surgical treatment of rectal cancer with prior chemoradiation: analysis of postoperative morbidity and survival

Authors: Janusz Olędzki, Maciej Chwaliński, Wojciech Rogowski, Rafał Sopyło, Marek P. Nowacki

Published in: International Journal of Colorectal Disease | Issue 2/2004

Abstract

Background and aims

Curative surgery for rectal cancer seldom requires urinary tract resections. The study investigated morbidity and survival following resection of rectum with total cystectomy following chemoradiation for primary rectal cancer.

Patients and methods

19 consecutive patients with primary nonresectable rectal cancer undergoing preoperative chemoradiation and operated on by a multidisciplinary team of surgeons.

Results

Morbidity was moderately low, and only five cases required surgical reintervention. No postoperative deaths were observed. Long-term survival in this group of patients compares well with the survival of patients with primarily nonresectable rectal cancer without the involvement of urinary bladder.

Conclusion

Extended pelvic exenteration due to rectal cancer is relatively safe and in selected patients offers long-term survival and a chance of a cure. Involvement of the urinary bladder does not adversely affect outcome of rectal cancer treatment.

Cohen AM, Minsky BD (1990) Aggressive surgical management of locally advanced primary and recurrent rectal cancer. Current status and future directions. Dis Colon Rectum 33:432–438PubMed

Pearlman NW, Stiegmann GV, Donohue RE (1989) Extended resection of fixed rectal cancer. Cancer 63:2438–2441PubMed

Wiig JN, Poulsen JP, Larsen S, Braendengen M, Waehre H, Giercksky KE (2002) Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg 168:42–48CrossRefPubMed

Farouk R, Nelson H, Gunderson LL (1997) Aggressive multimodality treatment for locally advanced irresectable rectal cancer. Br J Surg 84:741–749PubMed

Luna-Perez P, Rodriguez DF, Flores D, Delgado S, Labastida S (1995) Morbidity and mortality following preoperative radiation therapy and total pelvic exenteration for primary rectal adenocarcinoma. Surg Oncol 4:295–301PubMed

Rodel C, Grabenbauer GG, Matzel KE, Schick C, Fietkau R, Papadopoulos T, Martus P, Hohenberger W, Sauer R (2000) Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 43:312–319PubMed

Pearlman NW, Donohue RE, Stiegmann GV, Ahnen DJ, Sedlacek SM, Braun TJ (1987) Pelvic and sacropelvic exenteration for locally advanced or recurrent anorectal cancer. Arch Surg 122:537–541PubMed

Numa F, Ogata H, Suminami Y, Tsunaga N, Nakamura Y, Tamura H, Takasugi N, Kato H, Tangoku A, Uchiyama T, Oka M, Suzuki T, Yamamoto M, Naito K (1997) Pelvic exenteration for the treatment of gynecological malignancies. Arch Gynecol Obstet 259:133–138CrossRefPubMed

Miller B, Morris M, Levenback C, Burke TW, Gershenson DM (1995) Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol 58:202–205CrossRefPubMed

10.

Barakat RR, Goldman NA, Patel DA, Venkatraman ES, Curtin JP (1999) Pelvic exenteration for recurrent endometrial cancer. Gynecol Oncol 75:99–102CrossRefPubMed

11.

Kraybill WG, Lopez MJ, Bricker EM (1988) Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis. Surg Gynecol Obstet 166:259–263PubMed

12.

Averette HE, Lichtinger M, Sevin BU, Girtanner RE (1984) Pelvic exenteration: a 15-year experience in a general metropolitan hospital. Am J Obstet Gynecol 15:179–184

13.

Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T (2002) Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 45:1078–1084PubMed

14.

Law WL, Chu KW, Choi HK (2000) Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg 190:78–83CrossRefPubMed

15.

Luna-Perez P, Delgado S, Labastida S, Ortiz N, Rodriguez D, Herrera L (1996) Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma. Ann Surg Oncol 3:526–533PubMed

16.

Avradopoulos KA, Vezeridis MP, Wanebo HJ (1996) Pelvic exenteration for recurrent rectal cancer. Adv Surg 29:215–233PubMed

17.

Yeung RS, Moffat FL, Falk RE (1993) Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma. Cancer 72:1853–1858PubMed

18.

Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S (2003) Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum 46:474–480PubMed

19.

Eckhauser FE, Lindenauer SM, Morley GW (1979) Pelvic exenteration for advanced rectal carcinoma. Am J Surg 138:412–414PubMed

20.

Meterissian SH, Skibber JM, Giacco GG, el-Naggar AK, Hess KR, Rich TA (1997) Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. Surgery 121:479–487PubMed

21.

Ho YH, Cheng C, Tay SK (2001) Total pelvic exenteration: results from a multispecialty team approach to complex cancer surgery. Int Surg 86:107–111PubMed

22.

Muruve N (2003) Genitourinary tract preservation versus pelvic exenteration for advanced colorectal tumors. Can J Urol 10:1815–1818PubMed

23.

Sugarbaker PH, Gutman M, Verghese M (2003) Transureteroureterostomy: an adjunct to the management of advanced primary and recurrent pelvic malignancy. Int J Colorectal Dis 18:40–44CrossRefPubMed

Title: Total cystectomies in the surgical treatment of rectal cancer with prior chemoradiation: analysis of postoperative morbidity and survival
Authors: Janusz Olędzki
Maciej Chwaliński
Wojciech Rogowski
Rafał Sopyło
Marek P. Nowacki
Publication date: 01-03-2004
Publisher: Springer-Verlag
Published in: International Journal of Colorectal Disease / Issue 2/2004
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-003-0550-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Total cystectomies in the surgical treatment of rectal cancer with prior chemoradiation: analysis of postoperative morbidity and survival

Abstract

Background and aims

Patients and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background and aims

Patients and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2004

Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression

Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization

Gene therapy in the treatment of intestinal inflammation

Pelvic sidewall involvement in recurrent rectal cancer

A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene

Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer